** Drugmaker Liquidia's LQDA.O shares up 46.21% at $39.20 premarket
** Co says it settles all six pending lawsuits with United Therapeutics UTHR.O, ensuring uninterrupted access to YUTREPIA, a drug used to treat patients with a form of pulmonary hypertension
** Co to pay a net $380.7 mln in instalments through 2027 to resolve the litigation
** Stock down more than 22% YTD, as of last close
Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.
